These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8897116)

  • 41. Quantitative EEG in the prediction of antidepressant response to imipramine.
    Knott VJ; Telner JI; Lapierre YD; Browne M; Horn ER
    J Affect Disord; 1996 Jul; 39(3):175-84. PubMed ID: 8856421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Depression and functional EEG asymmetry].
    Cazard P; Ricard F; Facchetti L
    Ann Med Psychol (Paris); 1992; 150(2-3):230-9. PubMed ID: 1343525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoxetine treatment of depressed patients with HIV infection.
    Judd FK; Mijch AM; Cockram A
    Aust N Z J Psychiatry; 1995 Sep; 29(3):433-6. PubMed ID: 8573046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
    Grunze H; Marcuse A; Schärer LO; Born C; Walden J
    Neuropsychobiology; 2002; 46 Suppl 1():31-5. PubMed ID: 12571431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. All-night EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment.
    Luthringer R; Minot R; Toussaint M; Calvi-Gries F; Schaltenbrand N; Macher JP
    Biol Psychiatry; 1995 Jul; 38(2):98-104. PubMed ID: 7578656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.
    Rampello L; Nicoletti G; Raffaele R; Drago F
    Neuropsychobiology; 1995; 31(3):130-4. PubMed ID: 7609861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting factors for absenteeism in patients with major depressive disorders.
    Souêtre E; Lozet H; Cimarosti I
    Eur J Epidemiol; 1997 Jan; 13(1):87-93. PubMed ID: 9062785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine.
    Lôo H; Saiz-Ruiz J; Costa e Silva JACE ; Ansseau M; Herrington R; Vaz-Serra A; Dilling H; de Risio S
    J Affect Disord; 1999 Dec; 56(2-3):109-18. PubMed ID: 10701468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore.
    Tsoi WF; Tan CT; Kok LP
    Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of response to amine-specific antidepressants.
    Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
    J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of fluoxetine and dothiepin on 24-hour activity in depressed patients.
    Stanley N; Fairweather DB; Hindmarch I
    Neuropsychobiology; 1999; 39(1):44-8. PubMed ID: 9892859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations.
    Preskorn SH; Othmer SC; Lai CW; Othmer E
    J Clin Psychopharmacol; 1984 Oct; 4(5):262-4. PubMed ID: 6436340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients.
    Lôo H; Malka R; Defrance R; Barrucand D; Benard JY; Niox-Rivière H; Raab A; Sarda A; Vachonfrance G; Kamoun A
    Neuropsychobiology; 1988; 19(2):79-85. PubMed ID: 3067116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L; Septien L; Azoulay P
    CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.